The United Nations World Health Organization (WHO) said on Tuesday that a sample taken from a 24-year-old man identified as a relatively rare strain of Sudan.
That is For the first time in more than a decade, the Sudan strain was found in Ugandaalso witnessed an outbreak of the Zaire strain about Ebola virus in 2019.
The latest outbreak follows six suspicious deaths in Mubende district so far this month. There are also eight suspected cases are being cared for in a medical facility.
Dr Matshidiso Moeti, World Health Organization’s Regional Director for Africa, said the UN agency is working closely with Ugandan authorities to investigate the source and to support control efforts. control it.
“Uganda is no stranger to effective Ebola control,” she said. “Thanks to his expertise, people quickly took action to detect the virus and we can build on this knowledge to stop the spread of infections. ”
There is no effective vaccine
The WHO said existing vaccines against Ebola have proven effective against the Zaire strain but it is unclear whether they will be successful against the Sudan strain, the WHO said in a statement.
Ebola is a serious, often fatal disease that affects humans and other primates. It has six different strains, three of which – Bundibugyo, Sudan and Zaire – have previously caused major outbreaks.
The mortality rate of the Sudan strain has varied from 41% to 100% in previous outbreaks. WHO says early implementation of supportive treatment measures has been shown to significantly reduce Ebola deaths.
The agency has dispatched supplies to assist with patient care and is sending a specialized tent that will be used to isolate patients.
According to WHO, while round vaccination of high-risk individuals with Ervebo vaccine (rVSV-ZEBOV) has been highly effective in controlling the spread of Ebola during recent outbreaks in the DRC and other regions, In other words, this vaccine has only been approved to protect against the Zaire strain.
Another vaccine made by pharmaceutical company Johnson and Johnson may be effective but has yet to be tested specifically against the Sudan strain.